This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Ildikó Terebesi: Innovator in Pharmaceutical Chemistry
Introduction
Ildikó Terebesi is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug derivatives.
Latest Patents
Terebesi holds a patent for "Prodrug derivatives of substituted triazolopyridines." This invention relates to prodrug derivatives of Mps-1 kinase inhibitors, detailing processes for their preparation and their application in the treatment and/or prophylaxis of various diseases.
Career Highlights
Ildikó Terebesi is associated with Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. His work focuses on advancing therapeutic options through innovative chemical compounds.
Collaborations
Terebesi has collaborated with esteemed colleagues, including Volker Schulze and Hans-Georg Lerchen, to further enhance the impact of his research and inventions.
Conclusion
Ildikó Terebesi's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing new treatments. His work continues to influence the field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile